Overview
Tata India Pharma & Healthcare Fund Direct Growth
Tata Mutual Fund
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Investments in Tata India Pharma & Healthcare Fund Direct Growth are subject to market risks. Please read the offer document carefully before investing to understand the potential market risks and rewards.
Latest NAV
₹ 33.8122
Fund Size (AUM)
₹1183.65 Cr
Risk
Very High (Risk rating: 6/10)
Minimum Investment
Lumpsum: ₹ 5000
SIP: ₹100
Launch Date
28-Dec-2015
Expense Ratio
0.72%
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Benchmark
NIFTY Pharma Total Return Index
Standard Deviation
16.85
History
Performance & Ratios
1-Year SIP Return
-5.04%
3-Year SIP Return
22.78%
5-Year SIP Return
20.25%
Mean Return
0.38%
Alpha
0.55
Beta
0.96
Sharpe Ratio
0.82
Sortino Ratio
1.36
Information Ratio
0.01
Returns
| 1Y | 3Y | 5Y | All Time | |
|---|---|---|---|---|
| Fund Returns | 20.53% | 20.66% | 23.88% | 9.22% |
| Category Average | 19.46% | 17.92% | 21.75% | N/A |
| Rank Within Category | 9 | 4 | 5 | N/A |
Holdings (39)
| Company | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 11.79% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 7.27% |
| Cipla Ltd. | Healthcare | Equity | 5.97% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.66% |
| Lupin Ltd. | Healthcare | Equity | 5.2% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 5.12% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 5.05% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 3.91% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 3.5% |
| Wockhardt Ltd. | Healthcare | Equity | 3.31% |
Holdings Analysis
Peer Comparison
SIP, STP & SWP Details
Systematic Investment Plan (SIP):
Frequency: Monthly
Min Amount: ₹ 100
Multiplier: 1
Systematic Transfer Plan (STP):
Frequency: MONTHLY
Dates: 1, 7, 10, 20, 28
Min Amount: ₹ 500
Min Installments: 3
Systematic Withdrawal Plan (SWP):
Frequency: MONTHLY
Dates: Any day of the month
Min Amount: ₹ 500
Min Installments: 1
AMC Details
Asset Management Company
Tata Mutual Fund
Tata Mutual Fund started their mutual fund on 30/06/1995 and its managing total assets of ₹44,897 Cr. Its ranked at 13 as per total assets at end of 30th Sep 2017. Tata Mutual Fund employs robust strategies to manage market risks, but investments remain subject to market risks. Please read the fund’s documentation for detailed risk management policies.
Tata is one of the most trusted brands in India and has been successful in every field it has ventured to. Tata Mutual fund is known for its world-class service across the country and it has made a mark in the minds of investors.
It offers funds across various categories like, equity, debt, hybrid and sectoral. The motto of this AMC is to propel investing among the retail investors irrespective of their risk appetite, ideal investment duration, profession, salary or gender.
They believe in following a value-based investment methodology which enables them to attain consistent results over the years. They also believe in flexibility, by offering a large variety of funds across various market capitalization. Stability and integrity is one of the main pillar of business for Tata Mutual Fund and they believe in keeping an investor's money in the best possible hands.
Launch Date
1995-06-30T00:00:00.318Z
Total AUM
₹ 176558.15 Cr
Address
9th Floor, Mafatlal Centre,Nariman Point, Mumbai 400021
Phone
1800-209-0101
Website
Sub Type
Contra
Sub Type Info
Contra funds follow Contrarian strategy which means investing in stocks in contrast to the prevailing sentiment. Minimum investment in equity is 65%.
Tax Impact
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Stamp Duty
0.005% (from July 1st, 2020)
Fund Manager Details
Compare with Another Fund
Tata India Pharma & Healthcare Fund Direct Growth
Tata Mutual Fund
You May Be Interested In
HDFC Large and Mid Cap Fund Direct Growth
Large & MidCap
DSP ELSS Tax Saver Fund Direct Plan Growth
ELSS
SBI Banking & Financial Services Fund Direct Growth
Sectoral
Edelweiss Small Cap Fund Direct Growth
Small Cap
HDFC Large Cap Fund Direct Plan Growth
Large Cap
Franklin India Smaller Companies Fund Direct Growth
Small Cap
Kotak Infrastructure and Economic Reform Fund Direct Growth
Sectoral
Invesco India Infrastructure Fund Direct Growth
Sectoral
Invesco India Mid Cap Fund Direct Growth
Mid Cap
Franklin India Flexi Cap Fund Direct Growth
Flexi Cap
Explore More Mutual Funds
Debt Mutual Funds - Best Debt Fund Options
Discover top debt mutual funds for stable returns. Filter by NAV, fund size, and AMC to find the best debt funds for you.
Hybrid Mutual Funds - Top Hybrid Funds
Find top hybrid mutual funds for balanced growth. Filter by NAV, fund size, and risk to choose the best hybrid funds.
Commodities Mutual Funds
Explore commodities mutual funds for diversification. Filter by NAV and fund size to find the best commodity funds.
ELSS Mutual Funds - Top Tax-Saving Funds
Discover top ELSS mutual funds for tax savings and growth. Filter by NAV, fund size, and AMC to find the best ELSS funds.
Frequently Asked Questions
How is the overall rating calculated?
The overall rating for Tata India Pharma & Healthcare Fund Direct Growth is an aggregate score based on performance metrics (returns over 1, 3, and 5 years), risk-adjusted returns (Sharpe and Sortino ratios), and consistency relative to its category. Ratings are on a scale of 1 to 5, with 5 being the highest.
What are the top stocks of Tata India Pharma & Healthcare Fund Direct Growth?
The top stocks held by Tata India Pharma & Healthcare Fund Direct Growth include Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd..
Which industries does Tata India Pharma & Healthcare Fund Direct Growth invest in?
Tata India Pharma & Healthcare Fund Direct Growth primarily invests in the following industries: Healthcare, Services, Chemicals.
Who are the fund managers of Tata India Pharma & Healthcare Fund Direct Growth?
The fund managers of Tata India Pharma & Healthcare Fund Direct Growth are Meeta Shetty and Rajat Srivastava.
How many years has the fund manager been managing Tata India Pharma & Healthcare Fund Direct Growth?
Meeta Shetty:
Calculating...
Rajat Srivastava:
Calculating...
What is the minimum investment for Tata India Pharma & Healthcare Fund Direct Growth?
The minimum investment for Tata India Pharma & Healthcare Fund Direct Growth is ₹5000 for lumpsum investments and ₹100 for SIPs.
What are the average 1-year returns for Tata India Pharma & Healthcare Fund Direct Growth?
Calculating...
What are the average 3-year returns for Tata India Pharma & Healthcare Fund Direct Growth?
Calculating...
What is the expense ratio of Tata India Pharma & Healthcare Fund Direct Growth, and how does it compare to its category?
The expense ratio of Tata India Pharma & Healthcare Fund Direct Growth is 0.72%. No category comparison data is available.